C

CITY THERAPEUTICS, INC.

CTYPriced

CITY THERAPEUTICS, INC. · Nasdaq Global Market · Research source · 424B4 · 2026-10-16 · Latest filing · 8-K · 2026-11-10 SEC ↗

Report source
Research source · 424B4 · 2026-10-16
SummaryBASIC RESEARCHReport source · 424B4

City Therapeutics prices a clinical-stage RNAi IPO with substantial dilution and development-financing dependence.

As of the October 15, 2026 prospectus, City Therapeutics proposed an 11,111,111-share IPO at $18.00 per share; delivery was expected around October 19, 2026, not confirmed completed in the supplied evidence.

Ownership and votingAwaiting verified holder data— economic · — voting
Next disclosed checkpointExpected delivery was on or about October 19, 2026; completion and confirmed trading are not established by the supplied evidence.424B4 · 2026-10-16
Business and development direction

CITY THERAPEUTICS, INC.

Current business
Future development
DECISION DRIVERS

Key risks

Risk 1

The company has a limited operating history and no commercially approved products.

Risk 2

Clinical results may fail to demonstrate safety or efficacy or replicate preclinical results.

Risk 3

Third-party research, trial, supply and manufacturing performance may delay development.

Next checkExpected delivery was on or about October 19, 2026; completion and confirmed trading are not established by the supplied evidence.
Latest filing2026-11-10
Sources and calculation notes

Read this report’s SEC filing ↗

Calculation inputs
ViewSource basis
Offering qualitySome sourced inputs are available; a compatible set is needed for this view. Open filing ↗
BOOKRUNNERS / LEAD UNDERWRITERSUnderwriters named in the prospectus
CONFIRMED
#InstitutionUnderwriting allocationRatio · calculatedShares
1Goldman Sachs & Co. LLC41.00%4,555,556 shares
2Jefferies LLC35.00%3,888,889 shares
3Stifel, Nicolaus & Company, Incorporated18.00%2,000,000 shares
4Oppenheimer & Co. Inc.6.00%666,666 shares

Ratio = institution commitment ÷ complete source-table total (11,111,111 shares) × 100.

Source and calculation

Allocation ratios are calculated from each reported commitment and the complete total in the same source table; they are not ownership or fee percentages.

Underwriting purchase commitments as disclosed; shares; source class retained in the column header; source column: Number of Shares

Number of Shares

SEC table 30 row 6; source 2700509:2707836; SHA256 7a147d78c7f4c62385bbe75d38994d3335cc87f1ae6ecfc5b5dfd185c9ea7d76

Goldman Sachs & Co. LLC: 4555556 / 11111111 × 100

Jefferies LLC: 3888889 / 11111111 × 100

Stifel, Nicolaus & Company, Incorporated: 2000000 / 11111111 × 100

Oppenheimer & Co. Inc.: 666666 / 11111111 × 100

Source · 424B4 ↗

Underwriting terms

Underwriting terms
MeasureReported valueUnit
Underwriting discount per share$1.26$ / share
Total underwriting discount$14,000,000$
Source and calculation

Base prospectus offering; cover per-share and total columns Figures retain their stated source scenario and conditions.

Underwriting discount per share

Base prospectus offering; cover per-share and total columns

SEC table 1 row 3; source 5863:12752; SHA256 e44613efdd3fedb83b69263d742e5e267a55e90b4a479306de37cf4c6a8000e7 ↗

Base prospectus offering; cover per-share and total columns Figures retain their stated source scenario and conditions.

Total underwriting discount

Base prospectus offering; cover per-share and total columns

SEC table 1 row 3; source 5863:12752; SHA256 e44613efdd3fedb83b69263d742e5e267a55e90b4a479306de37cf4c6a8000e7 ↗

IPO CAPITAL QUALITY

Offering price $ / share$18
Gross offering amount $$199,999,998
Issuer proceeds before expenses $$185,999,998
Underwriting discount per share $ / share$1.26
Basis and evidence

424B4 · 2026-10-16

As of the October 15, 2026 prospectus, City Therapeutics proposed an 11,111,111-share IPO at $18.00 per share; delivery was expected around October 19, 2026, not confirmed completed in the supplied evidence.

Offering structure

Offering terms
MeasureReported valueUnit
Primary shares11,111,111Shares
Offering price$18$ / share
Gross offering amount$199,999,998$
Source and calculation

Shares offered by issuer Reported inputs; each row retains its own source basis.

Primary shares

Shares offered by issuer

Cover and opening disclosure ↗

Base prospectus offering; cover per-share and total columns Figures retain their stated source scenario and conditions.

Base prospectus offering; cover per-share and total columns Figures retain their stated source scenario and conditions.

Gross offering amount

Base prospectus offering; cover per-share and total columns

SEC table 1 row 2; source 5863:12752; SHA256 e44613efdd3fedb83b69263d742e5e267a55e90b4a479306de37cf4c6a8000e7 ↗

Proceeds and intended uses

Proceeds and intended uses
MeasureReported valueUnit
Issuer proceeds before expenses$185,999,998$
Source and calculation

Base prospectus offering; cover per-share and total columns Figures retain their stated source scenario and conditions.

Issuer proceeds before expenses

Base prospectus offering; cover per-share and total columns

SEC table 1 row 4; source 5863:12752; SHA256 e44613efdd3fedb83b69263d742e5e267a55e90b4a479306de37cf4c6a8000e7 ↗

Dilution and valuation

IPO price$18Final
Basic post-offer≈ 51.7212M
Equity value≈ $930.981M
Dilution and valuation
CalculationSharesValueReference
Base post-offer valuation≈ 51.7212M≈ $930.981M
Derived calculationFinalshares · $Basis and evidence 6 ↗
Post-offer shares — base/no option51,721,168—
Reported sourcePost-offer · BasesharesBasis and evidence 4 ↗
Post-offer shares — full option53,387,834—
Reported sourcePost-offer · Full optionsharesBasis and evidence 4 ↗
Offering price—$18
Reported sourceFinal$/shareBasis and evidence 3 ↗
Gross offering amount—$199,999,998
Reported source$Basis and evidence 3 ↗
Basis and evidence ↗
Basis and evidence 1

Prospectus share summary; Common stock to be outstanding immediately after this offering; 51,721,168 shares (or 53,387,834 shares if the underwriters exercise their option to purchase additional shares of common stock in full).; selected security: shares; selected scenario: base/no option; no inferred sum, conversion or equity value

Figures retain their stated source scenario and conditions.

SEC offering-summary columns; container 141630:147769 SHA256 bb1d100b65dbe6c3d56005968f7e307d693365808679add8aeee45a6af6975ee; label 143350:143656 SHA256 cc62955ce70ede646e0764306c12a18d772b67f4681fe4d4ec67b35a5697435b; value 143672:144059 SHA256 11456d56ea64837273b7753f4c1eef7f9cb6dd72186e7f90a5ac05d55873e0e3; source 143350:144059; SHA256 86bc26b58e538abae2a4a697225021fed881abd62ebd005e513dd22838d0c6e0 ↗

Basis and evidence 2

Prospectus share summary; Common stock to be outstanding immediately after this offering; 51,721,168 shares (or 53,387,834 shares if the underwriters exercise their option to purchase additional shares of common stock in full).; selected security: shares; selected scenario: full option; no inferred sum, conversion or equity value

Figures retain their stated source scenario and conditions.

SEC offering-summary columns; container 141630:147769 SHA256 bb1d100b65dbe6c3d56005968f7e307d693365808679add8aeee45a6af6975ee; label 143350:143656 SHA256 cc62955ce70ede646e0764306c12a18d772b67f4681fe4d4ec67b35a5697435b; value 143672:144059 SHA256 11456d56ea64837273b7753f4c1eef7f9cb6dd72186e7f90a5ac05d55873e0e3; source 143350:144059; SHA256 86bc26b58e538abae2a4a697225021fed881abd62ebd005e513dd22838d0c6e0 ↗

Basis and evidence 3

Base prospectus offering; cover per-share and total columns

Base prospectus offering; cover per-share and total columns Figures retain their stated source scenario and conditions.

SEC table 1 row 2; source 5863:12752; SHA256 e44613efdd3fedb83b69263d742e5e267a55e90b4a479306de37cf4c6a8000e7 ↗

Basis and evidence 4

completion-of-this-offering

Base prospectus offering; cover per-share and total columns

Prospectus share summary; Common stock to be outstanding immediately after this offering; 51,721,168 shares (or 53,387,834 shares if the underwriters exercise their option to purchase additional shares of common stock in full).; selected security: shares; selected scenario: base/no option; no inferred sum, conversion or equity value

Exact input · Offering price: $18

Exact input · Post-offer shares — base/no option: 51,721,168

Prospectus share summary; Common stock to be outstanding immediately after this offering; 51,721,168 shares (or 53,387,834 shares if the underwriters exercise their option to purchase additional shares of common stock in full).; selected security: shares; selected scenario: full option; no inferred sum, conversion or equity value

Exact input · Post-offer shares — full option: 53,387,834

SEC table 1 row 2; source 5863:12752; SHA256 e44613efdd3fedb83b69263d742e5e267a55e90b4a479306de37cf4c6a8000e7 ↗

SEC offering-summary columns; container 141630:147769 SHA256 bb1d100b65dbe6c3d56005968f7e307d693365808679add8aeee45a6af6975ee; label 143350:143656 SHA256 cc62955ce70ede646e0764306c12a18d772b67f4681fe4d4ec67b35a5697435b; value 143672:144059 SHA256 11456d56ea64837273b7753f4c1eef7f9cb6dd72186e7f90a5ac05d55873e0e3; source 143350:144059; SHA256 86bc26b58e538abae2a4a697225021fed881abd62ebd005e513dd22838d0c6e0 ↗

SEC valuation primary issuer cover; source 2528:2914; SHA256 d5a8c2ee60fe8cde8d47cd25d067e648e73b2c5cafa323ec411e6d5a21d04265 ↗

SEC valuation summary conditions; source 139153:143336; SHA256 514882bb41cbf9a234501297296c1108323b4beae1dadaa3f4efa74cad701750 ↗

SEC valuation summary conditions; source 144114:166636; SHA256 0debed2e335d4cc10651ebb545a3aebd64625f714840dbacdba954eb16082a9a ↗

Basis and evidence 6

completion-of-this-offering

Base prospectus offering; cover per-share and total columns

Prospectus share summary; Common stock to be outstanding immediately after this offering; 51,721,168 shares (or 53,387,834 shares if the underwriters exercise their option to purchase additional shares of common stock in full).; selected security: shares; selected scenario: base/no option; no inferred sum, conversion or equity value

Prospectus share summary; Common stock to be outstanding immediately after this offering; 51,721,168 shares (or 53,387,834 shares if the underwriters exercise their option to purchase additional shares of common stock in full).; selected security: shares; selected scenario: base/no option; no inferred sum, conversion or equity value

Base prospectus offering; cover per-share and total columns

Prospectus share summary; Common stock to be outstanding immediately after this offering; 51,721,168 shares (or 53,387,834 shares if the underwriters exercise their option to purchase additional shares of common stock in full).; selected security: shares; selected scenario: base/no option; no inferred sum, conversion or equity value

Exact input · Post-offer shares — base/no option: 51,721,168

Exact input · Offering price: $18

SEC table 1 row 2; source 5863:12752; SHA256 e44613efdd3fedb83b69263d742e5e267a55e90b4a479306de37cf4c6a8000e7 ↗

SEC offering-summary columns; container 141630:147769 SHA256 bb1d100b65dbe6c3d56005968f7e307d693365808679add8aeee45a6af6975ee; label 143350:143656 SHA256 cc62955ce70ede646e0764306c12a18d772b67f4681fe4d4ec67b35a5697435b; value 143672:144059 SHA256 11456d56ea64837273b7753f4c1eef7f9cb6dd72186e7f90a5ac05d55873e0e3; source 143350:144059; SHA256 86bc26b58e538abae2a4a697225021fed881abd62ebd005e513dd22838d0c6e0 ↗

SEC valuation primary issuer cover; source 2528:2914; SHA256 d5a8c2ee60fe8cde8d47cd25d067e648e73b2c5cafa323ec411e6d5a21d04265 ↗

SEC valuation summary conditions; source 139153:143336; SHA256 514882bb41cbf9a234501297296c1108323b4beae1dadaa3f4efa74cad701750 ↗

SEC valuation summary conditions; source 144114:166636; SHA256 0debed2e335d4cc10651ebb545a3aebd64625f714840dbacdba954eb16082a9a ↗

Share-count comparison

A compatible whole-issuer pre-offer share count is missing; existing-holder or offered-share allocations cannot substitute for it.

Source ↗
SCENARIO · NOT A FORECAST

IPO valuation scenario simulator

Offering completion · $18 × ≈ 51.7212M shares · Final

Implied equity value≈ $930.981MPrice × post-offer shares
Post-offer shares≈ 51.7212MShare count, not tradable float
Existing-holder ownership reduction0.0%Assumes new shares only; secondary sales do not increase shares.
Source and calculation ↗
Security and offer price

Reported point prices retain their security, class, currency and per-security unit; range endpoints remain separate.

Base post-offer shares

Reported whole-issuer base counts retain explicit option, conversion and surrender assumptions.

Equity value

Equity value is the exact product of the selected compatible per-share price and whole-issuer post-offer count.

Share-count change

A compatible whole-issuer pre-offer share count is missing; existing-holder or offered-share allocations cannot substitute for it.

Alternative scenarios

Each reported full-option, actual, diluted or class-specific case remains independent; no class sum or cross-date substitution is inferred.

Sensitivity

The exact selected base supports transparent hypothetical price/share changes; it is not a forecast or tradable float.

Source and calculation

The current source URL, accession, hash, proof variants, footnotes, input IDs and executable formulas remain attached. Missing source dates and precision gaps remain explicit.

$18 × 51,721,168 = $930,981,024 [summary-columns-143350-base-price, summary-columns-143350-base-post]

Exact calculation · Derived whole-issuer equity value: $930,981,024

Sources and calculation notes

Read this report’s SEC filing ↗

Calculation inputs
ViewSource basis
Ownership across stagesSome sourced inputs are available; a compatible set is needed for this view. Open filing ↗
As of
2026-10-16
!The supplied evidence gives aggregate control information but not a complete holder-by-holder economic and voting table. Existing preferred shares and the Biogen Note were assumed to convert before the offering.View source ↗
Relationship filters
Show
ownership / voting rights
share structure
Select for details · CITY THERAPEUTICS, INC.
Founder / personFund / entityPublic floatShare classEvery relationship is dated and linked to its supporting SEC filing. Percentages marked * are filing-based estimates.

Holdings and voting rights

Holder groups may overlap; these rows are not an additive ownership partition.

Holdings and voting rights
Holder / measureSharesOwnershipVoting rightsReference
ARCH Venture Fund XII, L.P.Beneficial shares13,522,507——
Shares of Common Stock Beneficially OwnedDisclosedEvidence
Invus Public Equities, L.P.Beneficial shares3,227,866——
Shares of Common Stock Beneficially OwnedDisclosedEvidence
FMR LLCBeneficial shares3,863,783——
Shares of Common Stock Beneficially OwnedDisclosedEvidence
Entities Affiliated with VikingBeneficial shares2,027,005——
Shares of Common Stock Beneficially OwnedDisclosedEvidence
Andrew (Andy) Orth, M.B.A. (5) President, Chief Executive Officer and DirectorBeneficial shares1,094,544——
Shares of Common Stock Beneficially OwnedDisclosedEvidence
Baisong Mei, M.D., Ph.D. (6) Chief Medical OfficerBeneficial shares234,678——
Shares of Common Stock Beneficially OwnedDisclosedEvidence
Tracy Zimmermann, Ph.D. (7) Chief Scientific OfficerBeneficial shares269,569——
Shares of Common Stock Beneficially OwnedDisclosedEvidence
John Maraganore, Ph.D.Beneficial shares2,121,831——
Shares of Common Stock Beneficially OwnedDisclosedEvidence
Barry GreeneBeneficial shares31,186——
Shares of Common Stock Beneficially OwnedDisclosedEvidence
Saraswathy (Sara) V. Nochur, Ph.D.Beneficial shares27,443——
Shares of Common Stock Beneficially OwnedDisclosedEvidence
Ron PhilipBeneficial shares33,680——
Shares of Common Stock Beneficially OwnedDisclosedEvidence
All executive officers and directors as a group (10 persons)Beneficial shares4,355,351——
Shares of Common Stock Beneficially OwnedDisclosedEvidence
ARCH Venture Fund XII, L.P.Beneficial ownership—34.96%Beneficial—
Percentage of Shares Beneficially Owned; Before OfferingDisclosedEvidence
ARCH Venture Fund XII, L.P.Beneficial ownership—26.03%Beneficial—
Percentage of Shares Beneficially Owned; After OfferingDisclosedEvidence
Invus Public Equities, L.P.Beneficial ownership—8.35%Beneficial—
Percentage of Shares Beneficially Owned; Before OfferingDisclosedEvidence
Invus Public Equities, L.P.Beneficial ownership—6.21%Beneficial—
Percentage of Shares Beneficially Owned; After OfferingDisclosedEvidence
FMR LLCBeneficial ownership—9.99%Beneficial—
Percentage of Shares Beneficially Owned; Before OfferingDisclosedEvidence
FMR LLCBeneficial ownership—7.44%Beneficial—
Percentage of Shares Beneficially Owned; After OfferingDisclosedEvidence
Entities Affiliated with VikingBeneficial ownership—5.24%Beneficial—
Percentage of Shares Beneficially Owned; Before OfferingDisclosedEvidence
Entities Affiliated with VikingBeneficial ownership—3.9%Beneficial—
Percentage of Shares Beneficially Owned; After OfferingDisclosedEvidence
Andrew (Andy) Orth, M.B.A. (5) President, Chief Executive Officer and DirectorBeneficial ownership—2.83%Beneficial—
Percentage of Shares Beneficially Owned; Before OfferingDisclosedEvidence
Andrew (Andy) Orth, M.B.A. (5) President, Chief Executive Officer and DirectorBeneficial ownership—2.11%Beneficial—
Percentage of Shares Beneficially Owned; After OfferingDisclosedEvidence
John Maraganore, Ph.D.Beneficial ownership—5.48%Beneficial—
Percentage of Shares Beneficially Owned; Before OfferingDisclosedEvidence
John Maraganore, Ph.D.Beneficial ownership—4.08%Beneficial—
Percentage of Shares Beneficially Owned; After OfferingDisclosedEvidence
All executive officers and directors as a group (10 persons)Beneficial ownership—11.14%Beneficial—
Percentage of Shares Beneficially Owned; Before OfferingDisclosedEvidence
All executive officers and directors as a group (10 persons)Beneficial ownership—8.32%Beneficial—
Percentage of Shares Beneficially Owned; After OfferingDisclosedEvidence
Our executive officers, directors, five percent stockholders and their affiliatesOwnership as disclosed—approximately 69.1%Beneficial—
Source statement; approximately ; source predicate: beneficially own; primary source clause; source condition: assuming no exercise of the underwriters’ option to purchase additional shares and no exercise of outstanding options and without giving effect to (i) any purchases by such persons in this offering or (ii) options granted to certain of our employee; source scope: of our common stock and, upon closing of this offering, that same group will beneficially own approximately; not an additive ownership partitionDisclosedEvidence
Our executive officers, directors, five percent stockholders and their affiliatesOwnership as disclosed—approximately 51.5%Beneficial—
Source statement; approximately ; source predicate: will beneficially own; primary source clause; source condition: assuming no exercise of the underwriters’ option to purchase additional shares and no exercise of outstanding options and without giving effect to (i) any purchases by such persons in this offering or (ii) options granted to certain of our employee; source scope: of our outstanding common stock (assuming no exercise of the underwriters’ option to purchase additional shares and no exercise of outstanding options and without giving effect to (i) any purchases b; not an additive ownership partitionDisclosedEvidence
Venture Fund XII, L.P.Ownership as disclosed—>5%Beneficial—
Source statement; >; source predicate: beneficially owns; primary source clause; full source conditions retained; source scope: of our outstanding capital stock; not an additive ownership partitionDisclosedEvidence
Invus Public Equities, L.P.Ownership as disclosed—>5%Beneficial—
Source statement; >; source predicate: beneficially owns; primary source clause; full source conditions retained; source scope: of our outstanding capital stock; not an additive ownership partitionDisclosedEvidence
FidelityOwnership as disclosed—>5%Beneficial—
Source statement; >; source predicate: beneficially owns; primary source clause; full source conditions retained; source scope: of our outstanding capital stock; not an additive ownership partitionDisclosedEvidence
VikingOwnership as disclosed—>5%Beneficial—
Source statement; >; source predicate: beneficially owns; primary source clause; full source conditions retained; source scope: of our outstanding capital stock; not an additive ownership partitionDisclosedEvidence
common stockper-share voting rights——1 vote per shareVotes per share
Literal source per-share voting entitlement; common stock; subject to the express source qualifications; full source conditions retained; not a holder voting percentage, ownership amount or controller finding; Source capital-stock section applies at the stated completion/consummation stage of this offering; certificate/bylaw effectiveness conditions remain applicableDisclosedEvidence
Source and calculation ↗
ARCH Venture Fund XII, L.P. · ARCH Venture Fund XII, L.P. — Beneficial shares · 13,522,507

Exact source ownership column: Shares of Common Stock Beneficially Owned; holders may overlap; not an additive partition

Raw source column: Shares of Common Stock Beneficially Owned; source holder: ARCH Venture Fund XII, L.P.(1)

0001104659-26-116636 · SEC table 29 row 4 columns 6; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:4 ↗

Invus Public Equities, L.P. · Invus Public Equities, L.P. — Beneficial shares · 3,227,866

Exact source ownership column: Shares of Common Stock Beneficially Owned; holders may overlap; not an additive partition

Raw source column: Shares of Common Stock Beneficially Owned; source holder: Invus Public Equities, L.P.(2)

0001104659-26-116636 · SEC table 29 row 5 columns 6; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:4 ↗

FMR LLC · FMR LLC — Beneficial shares · 3,863,783

Exact source ownership column: Shares of Common Stock Beneficially Owned; holders may overlap; not an additive partition

Raw source column: Shares of Common Stock Beneficially Owned; source holder: FMR LLC(3)

0001104659-26-116636 · SEC table 29 row 6 columns 6; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:4 ↗

Entities Affiliated with Viking · Entities Affiliated with Viking — Beneficial shares · 2,027,005

Exact source ownership column: Shares of Common Stock Beneficially Owned; holders may overlap; not an additive partition

Raw source column: Shares of Common Stock Beneficially Owned; source holder: Entities Affiliated with Viking(4)

0001104659-26-116636 · SEC table 29 row 7 columns 6; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:4 ↗

Andrew (Andy) Orth, M.B.A. (5) President, Chief Executive Officer and Director · Andrew (Andy) Orth, M.B.A. (5) President, Chief Executive Officer and Director — Beneficial shares · 1,094,544

Exact source ownership column: Shares of Common Stock Beneficially Owned; holders may overlap; not an additive partition

Raw source column: Shares of Common Stock Beneficially Owned; source holder: Andrew (Andy) Orth, M.B.A. (5) President, Chief Executive Officer and Director

0001104659-26-116636 · SEC table 29 row 9 columns 6; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:4 ↗

Baisong Mei, M.D., Ph.D. (6) Chief Medical Officer · Baisong Mei, M.D., Ph.D. (6) Chief Medical Officer — Beneficial shares · 234,678

Exact source ownership column: Shares of Common Stock Beneficially Owned; holders may overlap; not an additive partition

Raw source column: Shares of Common Stock Beneficially Owned; source holder: Baisong Mei, M.D., Ph.D. (6) Chief Medical Officer

0001104659-26-116636 · SEC table 29 row 10 columns 6; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:4 ↗

Tracy Zimmermann, Ph.D. (7) Chief Scientific Officer · Tracy Zimmermann, Ph.D. (7) Chief Scientific Officer — Beneficial shares · 269,569

Exact source ownership column: Shares of Common Stock Beneficially Owned; holders may overlap; not an additive partition

Raw source column: Shares of Common Stock Beneficially Owned; source holder: Tracy Zimmermann, Ph.D. (7) Chief Scientific Officer

0001104659-26-116636 · SEC table 29 row 11 columns 6; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:4 ↗

John Maraganore, Ph.D. · John Maraganore, Ph.D. — Beneficial shares · 2,121,831

Exact source ownership column: Shares of Common Stock Beneficially Owned; holders may overlap; not an additive partition

Raw source column: Shares of Common Stock Beneficially Owned; source holder: John Maraganore, Ph.D.(8)

0001104659-26-116636 · SEC table 29 row 12 columns 6; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:4 ↗

Barry Greene · Barry Greene — Beneficial shares · 31,186

Exact source ownership column: Shares of Common Stock Beneficially Owned; holders may overlap; not an additive partition

Raw source column: Shares of Common Stock Beneficially Owned; source holder: Barry Greene(9)

0001104659-26-116636 · SEC table 29 row 13 columns 6; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:4 ↗

Saraswathy (Sara) V. Nochur, Ph.D. · Saraswathy (Sara) V. Nochur, Ph.D. — Beneficial shares · 27,443

Exact source ownership column: Shares of Common Stock Beneficially Owned; holders may overlap; not an additive partition

Raw source column: Shares of Common Stock Beneficially Owned; source holder: Saraswathy (Sara) V. Nochur, Ph.D.(10)

0001104659-26-116636 · SEC table 29 row 15 columns 6; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:4 ↗

Ron Philip · Ron Philip — Beneficial shares · 33,680

Exact source ownership column: Shares of Common Stock Beneficially Owned; holders may overlap; not an additive partition

Raw source column: Shares of Common Stock Beneficially Owned; source holder: Ron Philip(11)

0001104659-26-116636 · SEC table 29 row 16 columns 6; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:4 ↗

All executive officers and directors as a group (10 persons) · All executive officers and directors as a group (10 persons) — Beneficial shares · 4,355,351

Exact source ownership column: Shares of Common Stock Beneficially Owned; holders may overlap; not an additive partition

Raw source column: Shares of Common Stock Beneficially Owned; source holder: All executive officers and directors as a group (10 persons) (12)

0001104659-26-116636 · SEC table 29 row 17 columns 6; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:4 ↗

ARCH Venture Fund XII, L.P. · ARCH Venture Fund XII, L.P. — Beneficial ownership · 34.96%

Exact source ownership column: Percentage of Shares Beneficially Owned; Before Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; Before Offering; source holder: ARCH Venture Fund XII, L.P.(1)

0001104659-26-116636 · SEC table 29 row 4 columns 12; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:7,2:4 ↗

ARCH Venture Fund XII, L.P. · ARCH Venture Fund XII, L.P. — Beneficial ownership · 26.03%

Exact source ownership column: Percentage of Shares Beneficially Owned; After Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; After Offering; source holder: ARCH Venture Fund XII, L.P.(1)

0001104659-26-116636 · SEC table 29 row 4 columns 18; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:7,2:7 ↗

Invus Public Equities, L.P. · Invus Public Equities, L.P. — Beneficial ownership · 8.35%

Exact source ownership column: Percentage of Shares Beneficially Owned; Before Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; Before Offering; source holder: Invus Public Equities, L.P.(2)

0001104659-26-116636 · SEC table 29 row 5 columns 12; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:7,2:4 ↗

Invus Public Equities, L.P. · Invus Public Equities, L.P. — Beneficial ownership · 6.21%

Exact source ownership column: Percentage of Shares Beneficially Owned; After Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; After Offering; source holder: Invus Public Equities, L.P.(2)

0001104659-26-116636 · SEC table 29 row 5 columns 18; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:7,2:7 ↗

FMR LLC · FMR LLC — Beneficial ownership · 9.99%

Exact source ownership column: Percentage of Shares Beneficially Owned; Before Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; Before Offering; source holder: FMR LLC(3)

0001104659-26-116636 · SEC table 29 row 6 columns 12; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:7,2:4 ↗

FMR LLC · FMR LLC — Beneficial ownership · 7.44%

Exact source ownership column: Percentage of Shares Beneficially Owned; After Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; After Offering; source holder: FMR LLC(3)

0001104659-26-116636 · SEC table 29 row 6 columns 18; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:7,2:7 ↗

Entities Affiliated with Viking · Entities Affiliated with Viking — Beneficial ownership · 5.24%

Exact source ownership column: Percentage of Shares Beneficially Owned; Before Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; Before Offering; source holder: Entities Affiliated with Viking(4)

0001104659-26-116636 · SEC table 29 row 7 columns 12; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:7,2:4 ↗

Entities Affiliated with Viking · Entities Affiliated with Viking — Beneficial ownership · 3.9%

Exact source ownership column: Percentage of Shares Beneficially Owned; After Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; After Offering; source holder: Entities Affiliated with Viking(4)

0001104659-26-116636 · SEC table 29 row 7 columns 18; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:7,2:7 ↗

Andrew (Andy) Orth, M.B.A. (5) President, Chief Executive Officer and Director · Andrew (Andy) Orth, M.B.A. (5) President, Chief Executive Officer and Director — Beneficial ownership · 2.83%

Exact source ownership column: Percentage of Shares Beneficially Owned; Before Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; Before Offering; source holder: Andrew (Andy) Orth, M.B.A. (5) President, Chief Executive Officer and Director

0001104659-26-116636 · SEC table 29 row 9 columns 12; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:7,2:4 ↗

Andrew (Andy) Orth, M.B.A. (5) President, Chief Executive Officer and Director · Andrew (Andy) Orth, M.B.A. (5) President, Chief Executive Officer and Director — Beneficial ownership · 2.11%

Exact source ownership column: Percentage of Shares Beneficially Owned; After Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; After Offering; source holder: Andrew (Andy) Orth, M.B.A. (5) President, Chief Executive Officer and Director

0001104659-26-116636 · SEC table 29 row 9 columns 18; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:7,2:7 ↗

John Maraganore, Ph.D. · John Maraganore, Ph.D. — Beneficial ownership · 5.48%

Exact source ownership column: Percentage of Shares Beneficially Owned; Before Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; Before Offering; source holder: John Maraganore, Ph.D.(8)

0001104659-26-116636 · SEC table 29 row 12 columns 12; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:7,2:4 ↗

John Maraganore, Ph.D. · John Maraganore, Ph.D. — Beneficial ownership · 4.08%

Exact source ownership column: Percentage of Shares Beneficially Owned; After Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; After Offering; source holder: John Maraganore, Ph.D.(8)

0001104659-26-116636 · SEC table 29 row 12 columns 18; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:7,2:7 ↗

All executive officers and directors as a group (10 persons) · All executive officers and directors as a group (10 persons) — Beneficial ownership · 11.14%

Exact source ownership column: Percentage of Shares Beneficially Owned; Before Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; Before Offering; source holder: All executive officers and directors as a group (10 persons) (12)

0001104659-26-116636 · SEC table 29 row 17 columns 12; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:7,2:4 ↗

All executive officers and directors as a group (10 persons) · All executive officers and directors as a group (10 persons) — Beneficial ownership · 8.32%

Exact source ownership column: Percentage of Shares Beneficially Owned; After Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; After Offering; source holder: All executive officers and directors as a group (10 persons) (12)

0001104659-26-116636 · SEC table 29 row 17 columns 18; source 2525443:2565626; SHA256 1c3e54d1f46b799e2b0b6a8c9b836d7efaf5590fedf34097487f6629e03dedaf; ownership header cells 1:7,2:7 ↗

Our executive officers, directors, five percent stockholders and their affiliates · Our executive officers, directors, five percent stockholders and their affiliates — Ownership as disclosed · approximately 69.1%

Source statement; approximately ; source predicate: beneficially own; primary source clause; source condition: assuming no exercise of the underwriters’ option to purchase additional shares and no exercise of outstanding options and without giving effect to (i) any purchases by such persons in this offering or (ii) options granted to certain of our employee; source scope: of our common stock and, upon closing of this offering, that same group will beneficially own approximately; not an additive ownership partition

Our executive officers, directors, five percent stockholders and their affiliates beneficially own approximately 69.1% of our common stock and, upon closing of this offering, that same group will beneficially own approximately 51.5% of our outstanding common stock (assuming no exercise of the underwriters’ option to purchase additional shares and no exercise of outstanding options and without giving effect to (i) any purchases by such persons in this offering or (ii) options granted to certain of our employees and non-employee directors upon pricing of this offering). Therefore, even after this offering, these stockholders will have the ability to influence us through their ownership positions. For example, these stockholders, acting together, may be able to exert significant influence over matters such as elections of directors, amendments of our organizational documents, or approval of any merger, sale of assets or other major corporate transaction. This may prevent or discourage unsolicited acquisition proposals or offers for our common stock that you may believe are in your best interest as one of our stockholders.

0001104659-26-116636 · SEC ownership paragraph; source 902518:903918; SHA256 11c82cd9079e14fde8c8afbd86cf9ef6b9e900d8f1e8f76a74a4f107be72bab6 ↗

Our executive officers, directors, five percent stockholders and their affiliates · Our executive officers, directors, five percent stockholders and their affiliates — Ownership as disclosed · approximately 51.5%

Source statement; approximately ; source predicate: will beneficially own; primary source clause; source condition: assuming no exercise of the underwriters’ option to purchase additional shares and no exercise of outstanding options and without giving effect to (i) any purchases by such persons in this offering or (ii) options granted to certain of our employee; source scope: of our outstanding common stock (assuming no exercise of the underwriters’ option to purchase additional shares and no exercise of outstanding options and without giving effect to (i) any purchases b; not an additive ownership partition

Our executive officers, directors, five percent stockholders and their affiliates beneficially own approximately 69.1% of our common stock and, upon closing of this offering, that same group will beneficially own approximately 51.5% of our outstanding common stock (assuming no exercise of the underwriters’ option to purchase additional shares and no exercise of outstanding options and without giving effect to (i) any purchases by such persons in this offering or (ii) options granted to certain of our employees and non-employee directors upon pricing of this offering). Therefore, even after this offering, these stockholders will have the ability to influence us through their ownership positions. For example, these stockholders, acting together, may be able to exert significant influence over matters such as elections of directors, amendments of our organizational documents, or approval of any merger, sale of assets or other major corporate transaction. This may prevent or discourage unsolicited acquisition proposals or offers for our common stock that you may believe are in your best interest as one of our stockholders.

0001104659-26-116636 · SEC ownership paragraph; source 902518:903918; SHA256 11c82cd9079e14fde8c8afbd86cf9ef6b9e900d8f1e8f76a74a4f107be72bab6 ↗

Venture Fund XII, L.P. · Venture Fund XII, L.P. — Ownership as disclosed · >5%

Source statement; >; source predicate: beneficially owns; primary source clause; full source conditions retained; source scope: of our outstanding capital stock; not an additive ownership partition

Robert Nelsen, M.B.A. serves as a member of our board of directors and is an affiliate of ARCH Venture Partners, of which Venture Fund XII, L.P. is an affiliated fund. Venture Fund XII, L.P. beneficially owns more than 5% of our outstanding capital stock.

0001104659-26-116636 · SEC ownership paragraph; source 2477732:2478277; SHA256 14994a52367cf93cec231d159749c3165240f002cf3febd45bda29b38fc9d248 ↗

Invus Public Equities, L.P. · Invus Public Equities, L.P. — Ownership as disclosed · >5%

Source statement; >; source predicate: beneficially owns; primary source clause; full source conditions retained; source scope: of our outstanding capital stock; not an additive ownership partition

Invus Public Equities, L.P. beneficially owns more than 5% of our outstanding capital stock.

0001104659-26-116636 · SEC ownership paragraph; source 2480301:2480636; SHA256 64b4d202359b62d5dd1b07196ec66fd0ae66b266e6e4026915b825cb15ceef07 ↗

Fidelity · Fidelity — Ownership as disclosed · >5%

Source statement; >; source predicate: beneficially owns; primary source clause; full source conditions retained; source scope: of our outstanding capital stock; not an additive ownership partition

Fidelity collectively refers to Powhatan & Co., LLC FBO Fidelity Growth Company Private Investments Portfolio LLC; Fidelity Mt. Vernon Street Trust: Fidelity Growth Company Fund; Fidelity Mt. Vernon Street Trust: Fidelity Growth Company K6 Fund; and Fidelity Mt. Vernon Street Trust: Fidelity Series Growth Company Fund. Fidelity beneficially owns more than 5% of our outstanding capital stock.

0001104659-26-116636 · SEC ownership paragraph; source 2481000:2481683; SHA256 8cfeea29a01105b63ede5bb908465b5b96c14f8ddc84ef19779e23a1540fae7c ↗

Viking · Viking — Ownership as disclosed · >5%

Source statement; >; source predicate: beneficially owns; primary source clause; full source conditions retained; source scope: of our outstanding capital stock; not an additive ownership partition

Viking collectively refers to Viking Global Opportunities Illiquid Investment Sub-Master LP and Viking Global Opportunities Vintage IV (Aggregator) LP. Viking beneficially owns more than 5% of our outstanding capital stock.

0001104659-26-116636 · SEC ownership paragraph; source 2496690:2497193; SHA256 da6ef64796607ceb60da00d05a8ba51f6eac31c64c98062f2595e17978e55408 ↗

common stock · common stock — per-share voting rights · 1 vote per share

Literal source per-share voting entitlement; common stock; subject to the express source qualifications; full source conditions retained; not a holder voting percentage, ownership amount or controller finding; Source capital-stock section applies at the stated completion/consummation stage of this offering; certificate/bylaw effectiveness conditions remain applicable

Holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of the stockholders. The holders of our common stock do not have any cumulative voting rights. Holders of our common stock are entitled to receive ratably any dividends declared by our board of directors out of funds legally available for that purpose, subject to any preferential dividend rights of any outstanding convertible preferred stock. Our common stock has no preemptive rights, conversion rights or other subscription rights or redemption or sinking fund provisions. Source context: The following description of our capital stock and certain provisions of our amended and restated certificate of incorporation and amended and restated bylaws are summaries and are qualified by reference to the amended and restated certificate of incorporation, which will become effective immediately prior to the completion of this offering, and the amended and restated bylaws, which became effective upon the effectiveness of the registration statement of which this prospectus forms a part. Copies of these documents have been filed with the SEC as exhibits to our registration statement, of which this prospectus forms a part. The descriptions of the common stock and preferred stock reflect changes to our capital structure that will be in effect on the completion of this offering.

0001104659-26-116636 · SEC ownership excerpt; source 2591030:2591855; SHA256 8c352caf84c7a248787214ab7eb37c4c50d7a288293120c8ac5bbf511e17c548; context source 2588283:2589317; SHA256 c8783d9938dfe1e881e2b05e6035dc059eeb3d82ba764c869e6406aa5d49833b ↗

Economic ownership

A chart needs complete, non-overlapping economic interests on one date and share basis. The disclosed holder figures remain in the table.

Share supply

Conditional lock-up duration

Lock-up period from prospectus date

Conditional lock-up duration
MeasureReported value
Conditional lock-up duration180 days
Source and calculation
Conditional lock-up duration

Lock-up period from prospectus date

UNDERWRITING ↗

Source lock-up conditions

Literal day restriction; source duration bound ≥; after date of this prospectus; full conditions and exceptions remain in the source paragraph

Source lock-up conditions
MeasureReported value
We, all of our directors and officers, and the holders of substantially all of our capital stock and securities convertible into or exchangeable for our capital stock≥180 days
Source and calculation
We, all of our directors and officers, and the holders of substantially all of our capital stock and securities convertible into or exchangeable for our capital stock

We, all of our directors and officers, and the holders of substantially all of our capital stock and securities convertible into or exchangeable for our capital stock have entered into lock-up agreements with the underwriters and/or are subject to market standoff agreements or other agreements with us, which prevents them from selling any of our common stock or any securities convertible into or exercisable or exchangeable for common stock for a period of not less than 180 days from the date of this prospectus without the prior written consent of Goldman Sachs & Co. LLC and Jefferies LLC, subject to certain exceptions. See the section titled “Underwriting” appearing elsewhere in this prospectus for more information.

SEC lock-up paragraph; source 2652654:2653745; SHA256 597d7c600bab40c0f44175fe091d9d563f0346213016780f0b17946ecf233856 ↗
Sources and calculation notes

Read this report’s SEC filing ↗

Calculation inputs
ViewSource basis
Conditional lock-up timelineSome sourced inputs are available; a compatible set is needed for this view. Open filing ↗

Financial quality

Bars compare absolute amounts within each measure. Each measure has its own scale.

Operating cash flow

$ · Annual values as reported · Consolidated
FY2024($20,391,000)
FY2025($41,611,000)
Financial quality
CalculationFY2024FY2025
Operating cash flowConsolidated($20,391,000)($41,611,000)
Financial quality
CalculationReported value
Cash and cash equivalents2024-12-31 · Consolidated$126,899,000
Cash and cash equivalents2025-12-31 · Consolidated$112,793,000
Current assets2024-12-31 · Consolidated$128,902,000
Current assets2025-12-31 · Consolidated$116,873,000
Total assets2024-12-31 · Consolidated$145,353,000
Total assets2025-12-31 · Consolidated$149,768,000
Current liabilities2024-12-31 · Consolidated$20,742,000
Current liabilities2025-12-31 · Consolidated$38,042,000
Total liabilities2024-12-31 · Consolidated$30,264,000
Total liabilities2025-12-31 · Consolidated$89,909,000
Total equity / (deficit)2024-12-31 · Consolidated($29,425,000)
Total equity / (deficit)2025-12-31 · Consolidated($84,655,000)
Cash and cash equivalents2025-12-31 · Consolidated · Unaudited$112,793,000
Cash and cash equivalents2026-06-30 · Consolidated · Unaudited$169,605,000
Current assets2025-12-31 · Consolidated · Unaudited$116,873,000
Current assets2026-06-30 · Consolidated · Unaudited$175,688,000
Total assets2025-12-31 · Consolidated · Unaudited$149,768,000
Total assets2026-06-30 · Consolidated · Unaudited$208,611,000
Current liabilities2025-12-31 · Consolidated · Unaudited$38,042,000
Current liabilities2026-06-30 · Consolidated · Unaudited$64,757,000
Total liabilities2025-12-31 · Consolidated · Unaudited$89,909,000
Total liabilities2026-06-30 · Consolidated · Unaudited$84,272,000
Total equity / (deficit)2025-12-31 · Consolidated · Unaudited($84,655,000)
Total equity / (deficit)2026-06-30 · Consolidated · Unaudited($131,717,000)
Operating cash flow6M ended 2025-06-30 · Consolidated · Unaudited($7,098,000)
Operating cash flow6M ended 2026-06-30 · Consolidated · Unaudited($43,158,000)
Basis and evidence
Cash and cash equivalents
December 31, 2024; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2024-12-31
Cash and cash equivalents
December 31, 2025; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
Total current assets
December 31, 2024; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2024-12-31
Total current assets
December 31, 2025; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
Total assets
December 31, 2024; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2024-12-31
Total assets
December 31, 2025; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
Total current liabilities
December 31, 2024; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2024-12-31
Total current liabilities
December 31, 2025; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
Total liabilities
December 31, 2024; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2024-12-31
Total liabilities
December 31, 2025; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
Total stockholders’ deficit
December 31, 2024; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2024-12-31
Total stockholders’ deficit
December 31, 2025; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
Net cash used in operating activities
FY2024; consolidated; currency symbol as printed ($); ISO currency not assigned; year ended 2024-12-31
Net cash used in operating activities
FY2025; consolidated; currency symbol as printed ($); ISO currency not assigned; year ended 2025-12-31
Cash and cash equivalents
December 31, 2025; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
Cash and cash equivalents
June 30, 2026; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2026-06-30
Total current assets
December 31, 2025; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
Total current assets
June 30, 2026; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2026-06-30
Total assets
December 31, 2025; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
Total assets
June 30, 2026; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2026-06-30
Total current liabilities
December 31, 2025; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
Total current liabilities
June 30, 2026; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2026-06-30
Total liabilities
December 31, 2025; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
Total liabilities
June 30, 2026; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2026-06-30
Total stockholders’ deficit
December 31, 2025; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
Total stockholders’ deficit
June 30, 2026; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2026-06-30
Net cash used in operating activities
6M ended 2025-06-30; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; 6 months ended 2025-06-30
Net cash used in operating activities
6M ended 2026-06-30; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; 6 months ended 2026-06-30
Financial quality and runway
Financial review

Financial quality and runway

The latest supplied full financial period was the six months ended June 30, 2026, with unaudited interim statements; a September 30 cash estimate was preliminary and unaudited. Revenue amounts, cash-flow data and debt balances were not supplied.

Cash and cash equivalents$126,899,000
Cash and cash equivalents$112,793,000
Total current assets$128,902,000
EvidenceFinancial review 1

Net loss was $53.4 million for the six months ended June 30, 2026, versus $24.3 million for the comparable 2025 period.

Source · Summary of Material Risks Associated With Our BusinessOpen 424B4 ↗
EvidenceFinancial review 2

Net loss was $58.5 million for 2025 and $27.8 million for 2024.

Source · Summary of Material Risks Associated With Our BusinessOpen 424B4 ↗
EvidenceFinancial review 3

Accumulated deficit was $142.5 million as of June 30, 2026.

EvidenceFinancial review 4

Estimated cash and cash equivalents at September 30, 2026 were approximately $141.9 million, preliminary and unaudited.

LATEST COMPARISON

MATERIAL CHANGES

The latest material signals and their investor impact are shown below.

Open 424B4 ↗
CHANGE 01Offer size

Why it mattersThe current filing increased the base primary offering.

Evidence · Cover and opening disclosure
CHANGE 02Offer price

Why it mattersThe current filing fixed the price at $18.00 rather than a $17–$19 estimate.

Evidence · Cover and opening disclosure
CHANGE 03Expected delivery

Why it mattersThe current filing supplied a specific expected delivery date; the prior filing left it blank.

Evidence · Cover and opening disclosure
IPO177 explains the investment effect; the SEC source remains the authoritative record. Page-level locators are shown only when extracted and verified.

Loading filing history…

Risk 1

The company has a limited operating history and no commercially approved products.

Risk 4

Future financing may dilute holders, while concentrated holders may influence directors and major transactions.

Evidence
DILUTION ↗
Document424B40001104659-26-116636
Filed2026-10-16SEC EDGAR
Research updated2026-10-17Analysed
Source-bound table inputs65SEC EDGAR
Open filing ↗